• KYODO

  • SHARE

The Japan Pharmaceutical Manufacturers Association on Friday opposed U.S. support for a temporary waiver of coronavirus vaccine patent rights held by pharmaceutical companies, saying such a move could exacerbate global shortages of vital components for vaccines and stoke anxiety about product quality.

Earlier this week, U.S. Trade Representative Katherine Tai said President Joe Biden’s administration will support the idea of an intellectual property waiver to help expand global vaccine supplies as part of efforts to end the COVID-19 pandemic.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)